Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights
Future Pharmacology · 13.11.2023 · 3 (4) · 877-907
DOI: 10.3390/futurepharmacol3040053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 13.11.2023. Verfasst von Kushagra Nagori und 4 weiteren Autor:innen. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative disease characterized by memory loss, personality changes, and cognitive impairment. It has become more prevalent in recent years. Therefore, understanding the pathophysiology of AD and developing efficient therapeutic strategies are essential. Moreover, the progression of the disease is unaffected by the pharmaceutical approaches discovered to date. Additionally, the failure of over 200 potential drug candidates in clinical trials over the past decade suggests the complexity and difficulty of both the disease and its underlying causes. Therefore, research focused on medicinal plant-based natural products in the search for novel neuroprotective therapeutic candidates for AD is essential. Indeed, several scientific investigations have demonstrated the efficacy of many medicinal plants and their principal phytochemicals in the treatment of AD. This review article covered the pathophysiological mechanisms of AD, the necessity for natural products as anti-AD treatments, and the most recent preclinical studies revealing the function of neuroprotective medicinal plants and their bioactive compounds in the effective management of AD. In addition, the review also presents clinical trial data of promising anti-AD formulations/agents of plant origin. Revealing recent findings and highlighting the clinical trial data related to the development of new treatments for AD would promote further research in this field and pave the way for the development of more effective and safe treatments for this debilitating disease.
Zitieren
APA
Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023). Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights. Future Pharmacology, 3(4), 877-907. https://doi.org/10.3390/futurepharmacol3040053
Vancouver
Nagori K, Nakhate KT, Yadav K, Ajazuddin, Pradhan M. Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights. Future Pharmacology. 2023;3(4):877-907. doi:10.3390/futurepharmacol3040053
BibTeX
@article{Nagori2023,
author = {Nagori, Kushagra and Nakhate, Kartik T. and Yadav, Krishna and Ajazuddin and Pradhan, Madhulika},
title = {Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights},
journal = {Future Pharmacology},
year = {2023},
volume = {3},
number = {4},
pages = {877--907},
doi = {10.3390/futurepharmacol3040053}
}
EUVIMED